Pulmonary Artery Pressure is Associated with Mid-Term Major Adverse Cardiovascular Events and Postprocedure Pericardial Effusion in Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion.
Tian Zou,Qingxing Chen,Lie Zhang,Chaofeng Chen,Yunlong Ling,Guijian Liu,Sunying Wang,Yang Pang,Ye Xu,Kuan Cheng,Daxin Zhou,Wenqing Zhu,Junbo Ge
DOI: https://doi.org/10.21037/atm-21-3561
IF: 3.616
2021-01-01
Annals of Translational Medicine
Abstract:Background: Patients with nonvalvular atrial fibrillation (NVAF) undergoing left atrial appendage occlusion (LAAO) are at high risk of stroke or bleeding. However, risk factors for their adverse cardiovascular events remain largely unknown. Pulmonary hypertension has been shown to be related to poor prognosis in many heart diseases. In this study, we determined whether elevated pulmonary artery systolic pressure (PASP) is associated with postprocedure adverse events and major adverse cardiovascular events (MACE) in these patients. Methods: From June 2017 and December 2019, 530 consecutive patients with NAVF at high risk of stroke or bleeding who undergone LAAO were retrospectively enrolled in our study. The preprocecure PASP was obtained by transthoracic echocardiography using the simplified Bernoulli’s equation. Patients were followed-up through clinic visits or over the phone at discharge at 1–3 months, 6 months, and annually thereafter. The median follow-up time was 12 months, and clinical data were analyzed. MACE was defined as myocardial infarction, definite heart failure, stroke, or all-cause death. The outcome of postprocedure pericardial effusion included in-hospital pericardial effusion and pericardial effusion detected after discharge. Results: Univariate analyses indicated that patients who had MACE tended to have elevated PASP (P=0.005). After dividing the cohort according to the cut-off value of PASP, Kaplan-Meier curves indicated that patients with PASP ≥39.5 mmHg had a higher risk of MACE (P=0.007) and heart failure hospitalization (P=0.005) compared to patients whose PASP <39.5 mmHg. Cox regression analysis showed that PASP was a predominant risk factor of MACE (HR =2.337, 95% CI, 1.207–4.526, P=0.012) and heart failure hospitalization (HR =3.701, 95% CI, 1.118–12.251, P=0.032). Furthermore, the PASP cut-off added incremental discriminatory capacity to the MACE risk model of this cohort. In addition, logistic regression showed that PASP had as a significant association with postprocedure pericardial effusion (OR =1.061, P=0.032). Conclusions: Elevated PASP was associated with postprocedure pericardial effusion and mid-term MACEs in patients with atrial fibrillation (AF) undergoing LAAO.